These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 8480281)
1. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Dewey SL; Smith GS; Logan J; Brodie JD; Fowler JS; Wolf AP Synapse; 1993 Apr; 13(4):350-6. PubMed ID: 8480281 [TBL] [Abstract][Full Text] [Related]
2. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride. Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219 [TBL] [Abstract][Full Text] [Related]
3. Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain. Volkow ND; Fowler JS; Gatley SJ; Dewey SL; Wang GJ; Logan J; Ding YS; Franceschi D; Gifford A; Morgan A; Pappas N; King P Synapse; 1999 Jan; 31(1):59-66. PubMed ID: 10025684 [TBL] [Abstract][Full Text] [Related]
5. Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study. Chou YH; Halldin C; Farde L Synapse; 2000 Nov; 38(2):138-43. PubMed ID: 11018787 [TBL] [Abstract][Full Text] [Related]
6. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system. Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499 [TBL] [Abstract][Full Text] [Related]
7. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. Dewey SL; Smith GS; Logan J; Alexoff D; Ding YS; King P; Pappas N; Brodie JD; Ashby CR J Neurosci; 1995 Jan; 15(1 Pt 2):821-9. PubMed ID: 7823183 [TBL] [Abstract][Full Text] [Related]
9. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Dewey SL; Smith GS; Logan J; Brodie JD; Simkowitz P; MacGregor RR; Fowler JS; Volkow ND; Wolf AP Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11816-20. PubMed ID: 8265632 [TBL] [Abstract][Full Text] [Related]
10. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats. Ginovart N; Wilson AA; Houle S; Kapur S Biol Psychiatry; 2004 Jun; 55(12):1188-94. PubMed ID: 15184038 [TBL] [Abstract][Full Text] [Related]
11. GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. Dewey SL; Smith GS; Logan J; Brodie JD; Yu DW; Ferrieri RA; King PT; MacGregor RR; Martin TP; Wolf AP J Neurosci; 1992 Oct; 12(10):3773-80. PubMed ID: 1357114 [TBL] [Abstract][Full Text] [Related]
12. SIC, an intracerebral beta(+)-range-sensitive probe for radiopharmacology investigations in small laboratory animals: binding studies with (11)C-raclopride. Zimmer L; Hassoun W; Pain F; Bonnefoi F; Lanièce P; Mastrippolito R; Pinot L; Pujol JF; Leviel V J Nucl Med; 2002 Feb; 43(2):227-33. PubMed ID: 11850489 [TBL] [Abstract][Full Text] [Related]
13. Effect of L-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum, quantified using PET. Hume SP; Opacka-Juffry J; Myers R; Ahier RG; Ashworth S; Brooks DJ; Lammertsma AA Synapse; 1995 Sep; 21(1):45-53. PubMed ID: 8525461 [TBL] [Abstract][Full Text] [Related]
14. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride. Jensen SB; Olsen AK; Pedersen K; Cumming P Synapse; 2006 Jun; 59(7):427-34. PubMed ID: 16485265 [TBL] [Abstract][Full Text] [Related]
15. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. Carson RE; Breier A; de Bartolomeis A; Saunders RC; Su TP; Schmall B; Der MG; Pickar D; Eckelman WC J Cereb Blood Flow Metab; 1997 Apr; 17(4):437-47. PubMed ID: 9143226 [TBL] [Abstract][Full Text] [Related]
16. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Hume SP; Myers R; Bloomfield PM; Opacka-Juffry J; Cremer JE; Ahier RG; Luthra SK; Brooks DJ; Lammertsma AA Synapse; 1992 Sep; 12(1):47-54. PubMed ID: 1411963 [TBL] [Abstract][Full Text] [Related]
17. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET. Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494 [TBL] [Abstract][Full Text] [Related]
18. Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects. Smith GS; Dewey SL; Brodie JD; Logan J; Vitkun SA; Simkowitz P; Schloesser R; Alexoff DA; Hurley A; Cooper T; Volkow ND Am J Psychiatry; 1997 Apr; 154(4):490-6. PubMed ID: 9090335 [TBL] [Abstract][Full Text] [Related]